Paul N. Hopkins mostly deals with Internal medicine, Endocrinology, Cardiology, Cholesterol and Familial hypercholesterolemia. His Endocrinology study frequently draws connections to adjacent fields such as Allele. His Cardiology research includes themes of Family history and Diastole.
Paul N. Hopkins focuses mostly in the field of Cholesterol, narrowing it down to topics relating to Hyperlipidemia and, in certain cases, Triglyceride. His Familial hypercholesterolemia research incorporates elements of Genetics, Pediatrics, Apolipoprotein B and Lipoprotein. His research in Pediatrics intersects with topics in Hyperlipoproteinemia Type II and Genetic testing.
Paul N. Hopkins mainly focuses on Internal medicine, Endocrinology, Blood pressure, Cardiology and Genetics. Internal medicine is a component of his Cholesterol, Body mass index, Lipoprotein, Renin–angiotensin system and Familial hypercholesterolemia studies. While the research belongs to areas of Body mass index, Paul N. Hopkins spends his time largely on the problem of Obesity, intersecting his research to questions surrounding Diabetes mellitus.
His Familial hypercholesterolemia study combines topics in areas such as LDL receptor, Disease, Pediatrics and Apolipoprotein B. As part of one scientific family, Paul N. Hopkins deals mainly with the area of Endocrinology, narrowing it down to issues related to the Single-nucleotide polymorphism, and often Haplotype. His studies in Cardiology integrate themes in fields like Odds ratio, Left ventricular hypertrophy, Diastole and Risk factor.
His primary areas of study are Internal medicine, Endocrinology, Familial hypercholesterolemia, Coronary artery disease and Alirocumab. Paul N. Hopkins is involved in the study of Internal medicine that focuses on Blood pressure in particular. His work deals with themes such as Genetic testing, Genotype, MEDLINE and Bioinformatics, which intersect with Familial hypercholesterolemia.
The various areas that Paul N. Hopkins examines in his Coronary artery disease study include Myocardial infarction, Revascularization, Pediatrics and Kidney transplantation. He has included themes like Stroke, Transplantation and Survival rate in his Cardiology study. Paul N. Hopkins has researched Diabetes mellitus in several fields, including Sphingolipid and Obesity.
His primary scientific interests are in Internal medicine, Endocrinology, Coronary artery disease, Diabetes mellitus and Inflammation. When carried out as part of a general Endocrinology research project, his work on Insulin resistance, LDL receptor, Apolipoprotein B and Familial hypercholesterolemia is frequently linked to work in Alirocumab, therefore connecting diverse disciplines of study. His Coronary artery disease study is related to the wider topic of Cardiology.
The study incorporates disciplines such as Odds ratio, Placebo, Menopause and Estrogen in addition to Cardiology. His work carried out in the field of Diabetes mellitus brings together such families of science as Framingham Risk Score, Sphingolipid, Heart disease and Cholesterol. His Inflammation study incorporates themes from Atrophy and Skeletal muscle.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Molecular basis of human hypertension: Role of angiotensinogen
Xavier Jeunemaitre;Florent Soubrier;Yuri V. Kotelevtsev;Richard P. Lifton;Richard P. Lifton.
Cell (1992)
Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients: Clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
Anne C. Goldberg;Paul N. Hopkins;Peter P. Toth;Christie M. Ballantyne.
Journal of Clinical Lipidology (2011)
Health Benefits of Gastric Bypass Surgery after 6 Years
Ted D. Adams;Lance E. Davidson;Sheldon E. Litwin;Sheldon E. Litwin;Ronette L. Kolotkin.
JAMA (2012)
Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease
Paul N. Hopkins;Lily L. Wu;Steven C. Hunt;Brent C. James.
Arteriosclerosis, Thrombosis, and Vascular Biology (1996)
Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics
Roger R. Williams;Roger R. Williams;Roger R. Williams;Steven C. Hunt;Steven C. Hunt;Steven C. Hunt;M.Catherine Schumacher;M.Catherine Schumacher;M.Catherine Schumacher;Robert A. Hegele;Robert A. Hegele;Robert A. Hegele.
American Journal of Cardiology (1993)
Familial and genetic determinants of systemic markers of inflammation : the NHLBI family heart study
James S Pankow;Aaron R Folsom;Mary Cushman;Ingrid B Borecki.
Atherosclerosis (2001)
A survey of 246 suggested coronary risk factors
Paul N Hopkins;Roger R Williams.
Atherosclerosis (1981)
Effect of Type 2 Diabetes Mellitus on Left Ventricular Geometry and Systolic Function in Hypertensive Subjects Hypertension Genetic Epidemiology Network (HyperGEN) Study
Vittorio Palmieri;Jonathan N. Bella;Donna K. Arnett;Jennifer E. Liu.
Circulation (2001)
Weight and Metabolic Outcomes 12 Years after Gastric Bypass
Ted D. Adams;Ted D. Adams;Lance E. Davidson;Lance E. Davidson;Sheldon E. Litwin;Jaewhan Kim.
The New England Journal of Medicine (2017)
Familial dyslipidemic hypertension. Evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension.
Roger R. Williams;Steven C. Hunt;Paul N. Hopkins;Barry M. Stults.
JAMA (1988)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Cornell University
University of South Carolina
Brigham and Women's Hospital
Tufts University
Cornell University
Wake Forest University
Washington University in St. Louis
Université Paris Cité
Washington University in St. Louis
University of Minnesota
Carnegie Mellon University
Karlsruhe Institute of Technology
University of Cambridge
Michigan Technological University
University of New South Wales
University of Washington
Medical University of South Carolina
Taiyuan University of Technology
Sanofi (France)
University of Toronto
Duke University
Leibniz Association
Ludwig-Maximilians-Universität München
Soochow University
University of Arizona
University Health Network